VJHemOnc is committed to improving our service to you

ISA 2020 | Frail populations in AL amyloidosis

VJHemOnc is committed to improving our service to you

Morie Gertz

Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, discusses frail populations in immunoglobulin light chain (AL) amyloidosis patients, defined as either a brain natriuretic peptide (BNP) of over 8500 or systolic blood pressure of less than 90, with a median survival of less than 6 months. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter